SCHEMBL5698501

SCHEMBL5698501

c1ccc2c(c1)c1cnccc1c1c(C3CCNCC3)[nH]nc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 3/20 0.39
MKNK2 Q9HBH9 3/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
FYN P06241 4/20 0.36
ILK Q13418 1/20 0.34
PIM1 P11309 4/20 0.34
PIM2 Q9P1W9 3/20 0.34
TLR9 Q9NR96 2/20 0.33
TLR8 Q9NR97 2/20 0.33
TLR7 Q9NYK1 2/20 0.33
ADRB2 P07550 1/20 0.33
HTR2C P28335 1/20 0.33
PARP1 P09874 1/20 0.33
SLC18A3 Q16572 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CDK9 P50750 1/20 0.33
KCNH2 Q12809 1/20 0.33
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5698454 0.69 PBRM1 (0.45) PIM1PIM2PARP1
Hydrochloric Acid SCHEMBL5698504 0.69 PARP1 (0.36) PIM1PIM2PARP1
SCHEMBL5698624 0.68 KDM4E (0.45) PIM1PIM2PARP1
SCHEMBL22048844 0.65 PARP1 (0.52) PIM1PARP1
SCHEMBL17298998 0.65 PARP1 (0.55) PIM1PARP1
SCHEMBL743939 0.65 PARP1 (0.55) PIM1PARP1
SCHEMBL15374747 0.65 PARP1 (0.55) PIM1PARP1
SCHEMBL15374721 0.65 PARP1 (0.55) PIM1PARP1
SCHEMBL5698400 0.63 PARP1 (0.44) PIM1PIM2PARP1
SCHEMBL5698452 0.63 KDM4E (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed